Michael Gesser
2021
In 2021, Michael Gesser earned a total compensation of $304.9K as Chief Finance Officer and Treasurer at Acorda Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $27,962 |
|---|---|
| Option Awards | $220,672 |
| Salary | $56,250 |
| Total | $304,884 |
Gesser received $220.7K in option awards, accounting for 72% of the total pay in 2021.
Gesser also received $28K in non-equity incentive plan and $56.3K in salary.
Rankings
In 2021, Michael Gesser's compensation ranked 11,593rd out of 12,415 executives tracked by ExecPay. In other words, Gesser earned more than 6.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,593 out of 12,415 | 7th |
Division Manufacturing | 5,104 out of 5,508 | 7th |
Major group Chemicals And Allied Products | 2,253 out of 2,378 | 5th |
Industry group Drugs | 2,000 out of 2,099 | 5th |
Industry Biological Products, Except Diagnostic Substances | 435 out of 449 | 3rd |
Pay ratio
| Michael Gesser's Pay | $304,884 |
|---|---|
| Median Employee's Pay | $226,642 |
| Pay Ratio | to 1 |
In 2021, the annual total compensation of Michael Gesser was $304,884.
The annual total compensation of the median employee at Acorda Therapeutics was $226,642.
The ratio of Michael Gesser's pay to the pay of median employee was therefore to one.
Source: SEC filing on April 27, 2023.
Gesser's colleagues
We found four more compensation records of executives who worked with Michael Gesser at Acorda Therapeutics in 2021.